Stay updated on T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Sign up to get notified when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3 tag and signaling a new build deployment.
    Difference
    0.0%
    Check dated 2026-05-18T18:26:52.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 333 was replaced by Taoyuan, Taiwan, 333 in the locations list, indicating a rename/correction of the Taiwan study site.
    Difference
    0.0%
    Check dated 2026-05-04T10:50:51.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer “Revision” label was updated from v3.5.2 to v3.5.3, reflecting a minor site/version change without altering the clinical study details.
    Difference
    0.0%
    Check dated 2026-04-27T08:00:09.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Revision v3.5.2; Removed Revision v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-20T05:06:24.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Replaced the location name Padua with Padova for the Italy site (Padova, 35128) to reflect the official local naming.
    Difference
    0.0%
    Check dated 2026-04-05T19:35:18.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Naples, Italy (80131) was added as a study site and Napoli, Italy (80131) was removed, with the city name updated to Naples and the revision upgraded from 3.4.3 to 3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T09:24:31.000Z thumbnail image

Stay in the know with updates to T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd vs Chemo in HER2-low HR+ MBC Clinical Trial page.